HTG Molecular Diagnostics Company Profile (NASDAQ:HTGM)

Analyst Ratings

Consensus Ratings for HTG Molecular Diagnostics (NASDAQ:HTGM) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.50 (128.22% upside)

Analysts' Ratings History for HTG Molecular Diagnostics (NASDAQ:HTGM)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2016Canaccord GenuityReiterated RatingBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Leerink SwannReiterated RatingOutperform$10.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015JMP SecuritiesInitiated CoverageOutperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for HTG Molecular Diagnostics (NASDAQ:HTGM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/12/2016Q1($0.83)($1.02)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/24/2016Q4($0.79)($0.83)$1.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.85)($0.76)$1.07 million$1.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.71)($1.73)$1.17 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/1/2015Q115($14.99)$1.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for HTG Molecular Diagnostics (NASDAQ:HTGM)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.83)($0.82)($0.83)
Q2 20162($0.86)($0.84)($0.85)
Q3 20162($0.83)($0.81)($0.82)
Q4 20162($0.84)($0.80)($0.82)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for HTG Molecular Diagnostics (NASDAQ:HTGM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for HTG Molecular Diagnostics (NASDAQ:HTGM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/4/2016Debra A GordonVPSell1,672$2.89$4,832.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016John L LubniewskiInsiderSell796$2.89$2,300.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Shaun D McmeansCFOSell1,601$2.89$4,626.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Tim B JohnsonCEOSell4,914$2.89$14,201.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Debra A GordonVPSell5,535$2.38$13,173.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016John L LubniewskiInsiderSell6,889$2.38$16,395.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Patrick C RocheSVPSell5,929$2.38$14,111.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Shaun D McmeansCFOSell5,651$2.38$13,449.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Tim B JohnsonCEOSell10,621$2.38$25,277.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Debra A GordonVPSell3,256$2.69$8,758.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016John L LubniewskiInsiderSell4,067$2.69$10,940.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Patrick C RocheSVPSell3,491$2.69$9,390.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Shaun D McmeansCFOSell3,325$2.69$8,944.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Tim B JohnsonCEOSell6,299$2.69$16,944.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Debra A GordonVPBuy1,000$5.16$5,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Patrick C. RocheSVPBuy6,500$5.76$37,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015John L LubniewskiInsiderBuy5,000$7.67$38,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015A/S NovoMajor ShareholderBuy365,106$14.00$5,111,484.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for HTG Molecular Diagnostics (NASDAQ:HTGM)
DateHeadline
07/21/16 04:40 PMHTG Molecular Diagnostics : Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay and HTG EdgeSeq System
07/21/16 10:33 AMHTG Molecular Diagnostics Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay and HTG EdgeSeq System
07/20/16 11:33 AMETF’s with exposure to HTG Molecular Diagnostics, Inc. : July 20, 2016 -
07/06/16 03:11 PMHTG Molecular Diagnostics and Firalis Announce Agreement to Develop a Theranostic Tool to Predict Response to Anti-TNF-alpha Therapies for Rheumatoid Arthritis - [at noodls] - TUCSON, Ariz. and HUNINGUE, France, July 06, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) ('HTG'), a provider of instruments and reagents for molecular profiling applications, ...
06/25/16 08:21 AMSlone Partners Places VP of North American Capital Sales at HTG Molecular Diagnostics
06/23/16 03:19 PMHTG Molecular Diagnostics Announces VERI/O Laboratory Service - [at noodls] - TUCSON, Ariz., June 23, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the introduction ...
06/21/16 04:13 PMHTG Molecular Diagnostics : Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform
06/20/16 03:19 PMHTG Molecular Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform - [at noodls] - TUCSON, Ariz., June 20, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for NGS-based molecular profiling applications, today announced the ...
05/28/16 12:18 PMBroker Roundup For HTG Molecular Diagnostics, Inc. (HTGM) - Share Trading News - Broker Roundup For HTG Molecular Diagnostics, Inc. (HTGM)Share Trading NewsThey now have a USD 21 price target on the stock. The share price of HTG Molecular Diagnostics, Inc. (HTGM) was up +0.00% during the last trading session, with a day high of 0.00. 0 shares were traded on HTG Molecular Diagnostics, Inc.'s last session.
05/18/16 04:38 PMEdited Transcript of HTGM earnings conference call or presentation 12-May-16 8:30pm GMT -
05/12/16 04:27 PMHTG Molecular Diagnostics Announces Immuno-Oncology Research Collaboration Agreement with Bristol-Myers Squibb - [at noodls] - TUCSON, Ariz., May 12, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced a research collaboration ...
05/12/16 04:27 PMHTG Molecular Diagnostics Reports First Quarter 2016 Results - [at noodls] - TUCSON, Ariz., May 12, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results ...
05/12/16 06:07 AMQ1 2016 HTG Molecular Diagnostics Inc Earnings Release - After Market Close -
05/03/16 03:30 PMDon Hardison Joins the Board of Directors for HTG Molecular Diagnostics - [at noodls] - TUCSON, Ariz., May 03, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that Donnie (Don) ...
05/02/16 03:20 PMHTG Molecular Diagnostics to Hold 2016 First Quarter Financial Results Conference Call on May 12, 2016 - [at noodls] - TUCSON, Ariz., May 02, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that the Company ...
03/31/16 03:07 PMHTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under a -
03/30/16 12:04 PMHTG MOLECULAR DIAGNOSTICS, INC Financials -
03/25/16 05:16 AMHTG MOLECULAR DIAGNOSTICS, INC Files SEC form 10-K, Annual Report -
03/24/16 11:56 PMEdited Transcript of HTGM earnings conference call or presentation 24-Mar-16 8:30pm GMT -
03/24/16 03:16 PMHTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results - [at noodls] - TUCSON, Ariz., March 24, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results ...
03/24/16 06:07 AMQ4 2015 HTG Molecular Diagnostics Inc Earnings Release - After Market Close -
03/21/16 03:34 PMHTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a -
03/21/16 03:02 PM4:02 pm HTG Molecular Diagnostics enters into a long-term agreement with Thermo Fisher Scientific (TMO) -
03/15/16 03:05 PMHTG Molecular Diagnostics to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 24, 2016 - [GlobeNewswire] - TUCSON, Ariz., March 15, 2016-- HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications, today announced that the Company will release 2015 fourth quarter ...
03/14/16 01:54 PMMorning Buzz: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Comcast Corporation (NASDAQ:CMCSA ... - KC Register - Morning Buzz: HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Comcast Corporation (NASDAQ:CMCSA ...KC RegisterHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)'s stock had its “buy” rating reiterated by stock analysts at Canaccord Genuity in a report issued. They presently have a $10.00 price objective on the stock. Canaccord Genuity's price target would indicate ...and more »
03/13/16 01:34 PMHTG Molecular Diagnostics, Inc. (HTGM) Analyst Updates - Risers & Fallers - Financial Market NewsHTG Molecular Diagnostics, Inc. (HTGM) Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of HTG Molecular Diagnostics, Inc. (HTGM). According to the latest broker reports outstanding on Friday 11th of March, 2 analysts have a rating of “strong buy”, 0 ...John L. Lubniewski Sells 4067 Shares of HTG Molecular Diagnostics Inc (HTGM) StockFinancial Market NewsHTG Molecular Diagnostics Inc (HTGM) CEO Tim B. Johnson Sells 6299 SharesThe Hilltop NewsTim B. Johnson Sells 6299 Shares of HTG Molecular Diagnostics Inc (HTGM) StockMicroCap MagazineThe Vista Voice -SCSUCollegian -Franklin Independentall 17 news articles »
03/09/16 01:38 PMAnalyst Coverage Updates – HTG Molecular Diagnostics, Inc. (HTGM) - Risers & Fallers - Analyst Coverage Updates – HTG Molecular Diagnostics, Inc. (HTGM)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of HTG Molecular Diagnostics, Inc. (HTGM). The latest broker reports which are currently outstanding on Monday 7th of March state 2 analysts have a rating of “strong buy”, ...
03/09/16 01:38 PMAverage Rating Update on HTG Molecular Diagnostics Inc (NASDAQ:HTGM) - Business Standard Tribune - Average Rating Update on HTG Molecular Diagnostics Inc (NASDAQ:HTGM)Business Standard TribuneWall Street analysts have an average broker recommendation of 1 on HTG Molecular Diagnostics Inc (NASDAQ:HTGM) shares. The rating is determined by taking the average of all analyst recommendations taken into consideration by Zacks Research.and more »
03/08/16 01:33 PMHTG Molecular Diagnostics Inc (NASDAQ:HTGM) Analyst Rating & Update - WallStreet.org - HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Analyst Rating & UpdateWallStreet.orgBoth the crowd and Wall Street have recently chimed on with their opinions of HTG Molecular Diagnostics Inc (NASDAQ:HTGM) shares. Beta Systems research tracks crows sourced sentiment and offers consensus ratings on stocks. These ratings come from ...and more »
03/04/16 12:55 PMHtg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorts Decreased by 16.63% After Short Covering - Franklin Independent - Htg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorts Decreased by 16.63% After Short CoveringFranklin IndependentThe short interest to Htg Molecular Diagnostics Incorporated's float is 1.14%. The stock increased 6.20% or $0.17 on March 3, hitting $2.91. About 16,717 shares traded hands. HTG Molecular Diagnostics Inc (NASDAQ:HTGM) has declined 70.69% since July ...HTG Molecular Diagnostics, Inc. (HTGM) New Analyst RatingsShare Trading Newsall 2 news articles »
03/03/16 01:21 PMHTG Molecular Diagnostics, Inc. (HTGM) New Analyst Ratings - Share Trading News - HTG Molecular Diagnostics, Inc. (HTGM) New Analyst RatingsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of HTG Molecular Diagnostics, Inc. (HTGM). The latest reports which are currently in issue on Thursday 3rd of March state 2 analysts have a rating of “strong buy”, 1 ...
02/29/16 01:18 PMHTG Molecular Diagnostics, Inc. (HTGM) Recent Analyst Updates - Risers & Fallers - HTG Molecular Diagnostics, Inc. (HTGM) Recent Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of HTG Molecular Diagnostics, Inc. (HTGM). According to the latest broker reports outstanding on Monday 29th of February, 2 analysts have a rating of “strong buy”, 1 ...Htg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorted Shares Decreased By 16.63%Stock Callerall 2 news articles »
02/28/16 12:30 PMStock on the Rise: HTG Molecular Diagnostics, Inc.( NASDAQ:HTGM ) - Franklin Independent - Stock on the Rise: HTG Molecular Diagnostics, Inc.( NASDAQ:HTGM )Franklin IndependentHTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) stock has moved in an upward direction over the past week, yielding a nice bump for investors. Based on a recent trade, the shares are up 14.53% over the past five trading days. Looking further out, the ...
02/17/16 12:35 PMCORRECTING and REPLACING – HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board - GlobeNewswire (press release) - CORRECTING and REPLACING – HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory BoardGlobeNewswire (press release)TUCSON, Ariz., Feb. 16, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), please note that in the header for the fourth paragraph of the release, the HTG SAB ...HTG Molecular Diagnostics Inc (NASDAQ:HTGM) Analyst Ratings in FocusUptick Analystall 13 news articles »
02/16/16 04:57 PMCORRECTING and REPLACING – HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board - [GlobeNewswire] - TUCSON, Ariz., Feb. 16, 2016-- In a release issued under the same headline earlier today by HTG Molecular Diagnostics, Inc., please note that in the header for the fourth paragraph of the release, the ...
02/16/16 03:01 PMHTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board - [GlobeNewswire] - TUCSON, Ariz., Feb. 16, 2016-- HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications, today announced the establishment of a Scientific Advisory Board ...
02/15/16 12:26 PMNew Price Targets On HTG Molecular Diagnostics, Inc. (HTGM) - Risers & Fallers - New Price Targets On HTG Molecular Diagnostics, Inc. (HTGM)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of HTG Molecular Diagnostics, Inc. (HTGM). The latest broker reports which are currently outstanding on Monday 15th of February state 2 analysts have a rating of “strong buy ...Htg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Sellers Covered 31.49% of Their Shortsfdanewsalert.comall 2 news articles »
02/10/16 12:19 PMHtg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorted Shares Increased 7.48% After Market Selling - fdanewsalert.com - Htg Molecular Diagnostics Incorporated (NASDAQ:HTGM) Shorted Shares Increased 7.48% After Market Sellingfdanewsalert.comThe short interest to Htg Molecular Diagnostics Incorporated's float is 1.99%. The stock is down 0.44% or $0.01 after the news, hitting $2.25 per share. HTG Molecular Diagnostics Inc (NASDAQ:HTGM) has declined 81.27% since July 7, 2015 and is ...
02/10/16 08:16 AMHTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Regulation FD Disclosure -
02/03/16 12:14 PMPrice Target Update On HTG Molecular Diagnostics, Inc. (HTGM) - Risers & Fallers - Price Target Update On HTG Molecular Diagnostics, Inc. (HTGM)Risers & FallersA number of investment brokers have recently updated their price targets on shares of HTG Molecular Diagnostics, Inc. (HTGM). According to the latest broker reports 2 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 ...
01/31/16 12:28 PMHTG Molecular Diagnostics, Inc. (HTGM) - 2-Dec-15 HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an 24-Nov-15 HTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Change in Directors or Principal Officers 12-Nov-15 HTG Molecular ...
01/28/16 12:49 PMHTG Molecular Diagnostics to Present at the Leerink Partners 5th Annual Global Healthcare Conference - GlobeNewswire (press release) - HTG Molecular Diagnostics to Present at the Leerink Partners 5th Annual Global Healthcare ConferenceGlobeNewswire (press release)TUCSON, Ariz., Jan. 27, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Leerink ...and more »
01/27/16 03:13 PMHTG Molecular Diagnostics to Present at the Leerink Partners 5th Annual Global Healthcare Conference - [at noodls] - , (GLOBE NEWSWIRE) -- , Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the 5 Annual Global Healthcare ...
01/26/16 01:49 PMAnalyst Coverage Updates - HTG Molecular Diagnostics, Inc. (HTGM) - Risers & Fallers - Analyst Coverage Updates - HTG Molecular Diagnostics, Inc. (HTGM)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of HTG Molecular Diagnostics, Inc. (HTGM). The latest broker reports which are currently outstanding on Tuesday 26th January state 2 analysts have a rating of “strong buy”, ...Brokerages Anticipate HTG Molecular Diagnostics Inc (NASDAQ:HTGM) to Post ($0.79) Earnings Per ShareIRA Market Reportall 2 news articles »
01/15/16 08:35 AMInvestors Flock to Pressure BioSciences as Its Patented PCT Platform Goes Mainstream - [Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / January 15, 2016 / Pressure BioSciences Inc. (OTCQB: PBIO) just announced that it exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 ...
11/12/15 03:30 PMHTG Molecular Diagnostics Inc Earnings Call scheduled for 4:30 pm ET today -
11/12/15 03:10 PMHTG MOLECULAR DIAGNOSTICS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement -
11/12/15 03:06 PMHTG Molecular Diagnostics Reports Third Quarter 2015 Results - [at noodls] - TUCSON, Ariz., Nov. 12, 2015 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results ...
11/12/15 06:07 AMQ3 2015 HTG Molecular Diagnostics Inc Earnings Release - After Market Close -
11/05/15 03:22 PMHTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum - [at noodls] - TUCSON, Ariz., Nov. 5, 2015 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management ...

Social

About HTG Molecular Diagnostics

HTG Molecular Diagnostics logoHTG Molecular Diagnostics, Inc. is a provider of instruments and reagents for molecular profiling applications. The Company has developed and markets a technology platform for the routine use of complex molecular profiling. The Company's HTG Edge platform, consisting of instrumentation, including HTG Edge and HTG EdgeSeq systems, consumables and software analytics, is used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. The Company's HTG EdgeSeq chemistry is an extension of its platform that automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The Company focuses on developing products that includes panels for translational research, drug development and molecular diagnostics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: HTGM
  • CUSIP:
Key Metrics:
  • Previous Close: $2.41
  • 50 Day Moving Average: $2.67
  • 200 Day Moving Average: $2.87
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $16.89M
  • Beta: 0.32
  • Current Year EPS Consensus Estimate: $-3.82 EPS
  • Next Year EPS Consensus Estimate: $-3.62 EPS
Additional Links:
HTG Molecular Diagnostics (NASDAQ:HTGM) Chart for Thursday, July, 28, 2016